These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11889427)

  • 1. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
    Stempfle HU; Werner C; Siebert U; Assum T; Wehr U; Rambeck WA; Meiser B; Theisen K; Gärtner R
    Transplantation; 2002 Feb; 73(4):547-52. PubMed ID: 11889427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
    Stempfle HU; Werner C; Echtler S; Wehr U; Rambeck WA; Siebert U; Uberfuhr P; Angermann CE; Theisen K; Gärtner R
    Transplantation; 1999 Aug; 68(4):523-30. PubMed ID: 10480411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
    Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcitriol on bone loss after cardiac or lung transplantation.
    Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
    J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
    Josephson MA; Schumm LP; Chiu MY; Marshall C; Thistlethwaite JR; Sprague SM
    Transplantation; 2004 Oct; 78(8):1233-6. PubMed ID: 15502727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.
    Cohen A; Addesso V; McMahon DJ; Staron RB; Namerow P; Maybaum S; Mancini D; Shane E
    Transplantation; 2006 Mar; 81(5):686-91. PubMed ID: 16534469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
    Scolapio JS; DeArment J; Hurley DL; Romano M; Harnois D; Weigand SD
    JPEN J Parenter Enteral Nutr; 2003; 27(6):427-32. PubMed ID: 14621125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
    Shane E; Addesso V; Namerow PB; McMahon DJ; Lo SH; Staron RB; Zucker M; Pardi S; Maybaum S; Mancini D
    N Engl J Med; 2004 Feb; 350(8):767-76. PubMed ID: 14973216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
    Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
    Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of bone disease at 2 years after transplantation: a single-center study.
    Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
    Jeffery JR; Leslie WD; Karpinski ME; Nickerson PW; Rush DN
    Transplantation; 2003 Nov; 76(10):1498-502. PubMed ID: 14657693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.